The first half of the 2022 J.P. Morgan Healthcare Conference has seen big names in the in vitro diagnostics sector. Guardant Health, Illumina, Thermo Fisher Scientific, and Ortho Clinical Diagnostics were among the IVD makers offering insight on the impacts of COVID, recent deals, and future developments.
A key takeaway from all companies speaking was that in IVD, big “news” comes slowly. Years, if not decades of...